Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2018 Dec 1;198(11):1397-1405.
doi: 10.1164/rccm.201804-0663OC.

Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study

Emily S Wan  1   2 , Spyridon Fortis  3 , Elizabeth A Regan  4 , John Hokanson  5 , MeiLan K Han  6 , Richard Casaburi  7 , Barry J Make  4 , James D Crapo  4 , Dawn L DeMeo  1 , Edwin K Silverman  1 ; COPDGene Investigators
Collaborators, Affiliations
Observational Study

Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study

Emily S Wan et al. Am J Respir Crit Care Med. .

Erratum in

Abstract

Rationale: Increasing awareness of the prevalence and significance of Preserved Ratio Impaired Spirometry (PRISm), alternatively known as restrictive or Global Initiative for Chronic Obstructive Lung Disease (GOLD)-unclassified spirometry, has expanded the body of knowledge on cross-sectional risk factors. However, longitudinal studies of PRISm remain limited.

Objectives: To examine longitudinal patterns of change in lung function, radiographic characteristics, and mortality of current and former smokers with PRISm.

Methods: Current and former smokers, aged 45 to 80 years, were enrolled in COPDGene (phase 1, 2008-2011) and returned for a 5-year follow-up (phase 2, 2012-2016). Subjects completed questionnaires, spirometry, chest computed tomography scans, and 6-minute-walk tests at both study visits. Baseline characteristics, longitudinal change in lung function, and mortality were assessed by post-bronchodilator lung function categories: PRISm (FEV1/FVC < 0.7 and FEV1 < 80%), GOLD0 (FEV1/FVC > 0.7 and FEV1 > 80%), and GOLD1-4 (FEV1/FVC < 0.7).

Measurements and main results: Although the prevalence of PRISm was consistent (12.4-12.5%) at phases 1 and 2, subjects with PRISm exhibited substantial rates of transition to and from other lung function categories. Among subjects with PRISm at phase 1, 22.2% transitioned to GOLD0 and 25.1% progressed to GOLD1-4 at phase 2. Subjects with PRISm at both phase 1 and phase 2 had reduced rates of FEV1 decline (-27.3 ± 42.1 vs. -33.0 ± 41.7 ml/yr) and comparable proportions of normal computed tomography scans (51% vs. 52.7%) relative to subjects with stable GOLD0 spirometry. In contrast, incident PRISm exhibited accelerated rates of lung function decline. Subjects with PRISm at phase 1 had higher mortality rates relative to GOLD0 and lower rates relative to the GOLD1-4 group.

Conclusions: PRISm is highly prevalent, is associated with increased mortality, and represents a transitional state for significant subgroups of subjects. Additional studies to characterize longitudinal progression in PRISm are warranted.

Trial registration: ClinicalTrials.gov NCT00608764.

Keywords: lung disease epidemiology; spirometry classification; spirometry mortality; spirometry statistics and numerical data.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Kaplan-Meier plot of mortality by lung function category in the COPDGene cohort (nGOLD0 = 3,783, nPRISm = 1,058, nGOLD1–4 = 3,959). PRISm: FEV1/FVC ≥ 0.7 and FEV1 < 80% predicted; GOLD0: FEV1/FVC ≥ 0.7 and FEV1 ≥ 80% predicted; GOLD1–4: FEV1/FVC < 0.7. GOLD = Global Initiative for Chronic Obstructive Lung Disease; PRISm = Preserved Ratio Impaired Spirometry.
Figure 2.
Figure 2.
Forest plot of hazard ratios for mortality from Cox proportional hazards model. PRISm: FEV1/FVC ≥ 0.7 and FEV1 < 80% predicted; GOLD0: FEV1/FVC ≥ 0.7 and FEV1 ≥ 80% predicted; GOLD1–4: FEV1/FVC < 0.7. **P < 0.01; ***P < 0.001. AIC = Akaike information criterion; BMI = body mass index; GOLD = Global Initiative for Chronic Obstructive Lung Disease; PRISm = Preserved Ratio Impaired Spirometry.
Figure 3.
Figure 3.
Change in lung function categories among subjects with Preserved Ratio Impaired Spirometry (PRISm) at (A) phase 1 and (B) phase 2. COPD = chronic obstructive pulmonary disease; GOLD = Global Initiative for Chronic Obstructive Lung Disease.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wan ES, Hokanson JE, Murphy JR, Regan EA, Make BJ, Lynch DA, et al. COPDGene Investigators. Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med. 2011;184:57–63. - PMC - PubMed
    1. Iyer VN, Schroeder DR, Parker KO, Hyatt RE, Scanlon PD. The nonspecific pulmonary function test: longitudinal follow-up and outcomes. Chest. 2011;139:878–886. - PubMed
    1. Wan ES, Castaldi PJ, Cho MH, Hokanson JE, Regan EA, Make BJ, et al. COPDGene Investigators. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res. 2014;15:89. - PMC - PubMed
    1. Backman H, Eriksson B, Hedman L, Stridsman C, Jansson SA, Sovijärvi A, et al. Restrictive spirometric pattern in the general adult population: methods of defining the condition and consequences on prevalence. Respir Med. 2016;120:116–123. - PubMed
    1. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax. 2003;58:388–393. - PMC - PubMed

Publication types

MeSH terms

Associated data